These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 8630374)
1. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374 [TBL] [Abstract][Full Text] [Related]
2. Human platelets as a model for the binding and degradation of thrombopoietin. Fielder PJ; Hass P; Nagel M; Stefanich E; Widmer R; Bennett GL; Keller GA; de Sauvage FJ; Eaton D Blood; 1997 Apr; 89(8):2782-8. PubMed ID: 9108396 [TBL] [Abstract][Full Text] [Related]
3. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Li J; Xia Y; Kuter DJ Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590 [TBL] [Abstract][Full Text] [Related]
4. Human platelets display high-affinity receptors for thrombopoietin. Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709 [TBL] [Abstract][Full Text] [Related]
5. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Li J; Xia Y; Kuter DJ Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159 [TBL] [Abstract][Full Text] [Related]
6. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Stefanich E; Senn T; Widmer R; Fratino C; Keller GA; Fielder PJ Blood; 1997 Jun; 89(11):4063-70. PubMed ID: 9166846 [TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Stoffel R; Wiestner A; Skoda RC Blood; 1996 Jan; 87(2):567-73. PubMed ID: 8555478 [TBL] [Abstract][Full Text] [Related]
11. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761 [TBL] [Abstract][Full Text] [Related]
12. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025 [TBL] [Abstract][Full Text] [Related]
13. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow. Wang JC; Hashmi G Leuk Res; 2003 Jan; 27(1):13-7. PubMed ID: 12479847 [TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenia in c-mpl-deficient mice. Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287 [TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin and the c-Mpl receptor: insights from gene targeting. Alexander WS Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337 [TBL] [Abstract][Full Text] [Related]
16. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234 [TBL] [Abstract][Full Text] [Related]
17. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels. Geddis AE; Fox NE; Kaushansky K Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394 [TBL] [Abstract][Full Text] [Related]
18. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro. Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567 [TBL] [Abstract][Full Text] [Related]
19. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo. Scheding S; Bergmann M; Shimosaka A; Wolff P; Driessen C; Rathke G; Jaschonek K; Brugger W; Kanz L Transfusion; 2002 Mar; 42(3):321-7. PubMed ID: 11961237 [TBL] [Abstract][Full Text] [Related]
20. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice. Chang M; Qian JX; Lee SM; Joubran J; Fernandez G; Nichols J; Knoppel A; Buzby JS Blood; 1999 Apr; 93(8):2515-24. PubMed ID: 10194430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]